Fusion driven JMML: a novel CCDC88C-FLT3 fusion responsive to sorafenib identified by RNA sequencing

Leukemia. 2020 Feb;34(2):662-666. doi: 10.1038/s41375-019-0549-y. Epub 2019 Sep 12.

Alexander K Chao¹, Julia A Meyer¹, Alex G Lee¹, Anna Hecht¹, Theodore Tarver², Jessica Van Ziffle³, Ashley K Koegel¹, Carla Golden⁴, Benjamin S Braun^{1

5}, E Alejandro Sweet-Cordero^{1

5}, Catherine C Smith^{2

5}, Christopher C Dvorak^{1

5}, Mignon L Loh^{1

5}, Elliot Stieglitz^{6

7}

¹ Department of Pediatrics, Benioff Children's Hospital, University of California, San Francisco, San Francisco, CA, USA.
² Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
³ Department of Pathology, University of California, San Francisco, San Francisco, CA, USA.
⁴ Department of Pediatrics, Benioff Children's Hospital, University of California, San Francisco, Oakland, CA, USA.
⁵ Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.
⁶ Department of Pediatrics, Benioff Children's Hospital, University of California, San Francisco, San Francisco, CA, USA. [email protected].
⁷ Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. [email protected].

No abstract available

Publication types